N/A N=18 Health Services Research

Assessing Visual Feedback of HR Monitoring in Rehabilitation - Pilot

Exercise Therapy · Heart Rate Determination

Bottom Line

View on ClinicalTrials.gov: NCT05273801 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Dec 2024

Primary outcome: Primary: Provider Behavior — 0.38; 0.48; 0.62; 1.43 observations — p=0.73

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Heart Rate Recording from Multiple Participants, No Visual Feedback (Device); Visual Feedback of Multiple Participant Heart Rates (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Shirley Ryan AbilityLab
Primary completion: May 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY Provider Behavior	0.38; 0.48; 0.62; 1.43; 0.33; 4.91	0.73
SECONDARY Patient Participant Self-Efficacy and Confidence	72.9; 77.5; 85.0; 79.3	—

Summary

Monitoring heart rate during exercise can provide feedback to the patient and provider that the patient is exercising in the appropriate, individualized and safe range for them. This is particularly important in a group setting when multiple individuals are supervised by one provider. This study is interested in assessing the difference in intensity of care delivered when visual feedback of heart rate is provided compared to no visual feedback of heart rate in rehabilitation. Visual feedback of heart rate will be provided through Heart Zones, a platform which synthesizes multiple signals from externally worn heart rate monitors. This study is interested in better understanding the acceptability, feasibility and appropriateness of this technology when used in rehabilitation.

Eligibility Criteria

Inclusion Criteria

Admitted to inpatient rehabilitation, day rehabilitation or participant in community fitness
Qualifies for group therapy based on diagnosis and insurance reimbursement
Physician clearance for participation

Exclusion Criteria

Unable to provide informed consent due to cognitive impairment
Inability to communicate with investigators
Sternal Precautions
Individuals with Left Ventricular assist devices
Pregnant women
Uncontrolled Hypertension
Serious and unstable cardiac arrhythmias
Loss of bilateral upper extremity sensation
At high risk for skin breakdown due to poor skin integrity (open wound, fragile skin, etc)
Previous participation in this study while in another level of care in the last 6 months

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05273801). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.